Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR

Vaccine

Volumn 14, Issue 6, 1996, Pages 526-531

  Favre, Didier ^a   Struck, Mark Michael ^a   Cryz Jr , Stanley J ^a   Viret, Jean François ^a  

^a Berna Biotech AG   (Switzerland)

Author keywords

Genetic stability; Vaccine safety; Vibrio cholerae CVD103 HgR

Indexed keywords

CHOLERA VACCINE; LIVE VACCINE; MERCURY; RECOMBINANT VACCINE;

ARTICLE; BACTERIOPHAGE; DRUG SAFETY; GENETIC STABILITY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIBRIO CHOLERAE;

EID: 0030011422     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00218-P     Document Type: Article

References (27)

1. Levine, M.M. and Pierce, N.F. Immunity and vaccine development. In: Cholera (Eds Greenough, W.B. III and Barua, D.). Plenum Press, New York, 1992, pp. 288-327
2. Levine, M.M. and Kaper, J.B. Live oral vaccines against cholera: an update. Vaccine 1993, 11, 207-212
3. Levine, M.M., Herrington, D., Losonsky, G. et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-HgR. Lancet 1988, ii, 467-470
4. Ketley, J.M., Michalski, J., Galen, M.M., Levine, M.M. and Kaper, J.B. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol. Lett. 1993, 111, 15-22
5. Kaper, J.B., Mobley, H.L.T., Michalski, J.M., Herrington, D.A. and Levine, M.M. Recent advances in developing a safe and effective live oral attenuated Vibrio cholerae vaccine. In: Advances in Research on Cholera and Related Diarrheas, Vol. 6 (Eds Ohtomo, N. and Sack, R.B.). KTK Scientific Publishers, Tokyo, 1988, pp. 161-167
6. Barrineau, P., Gilbert, P., Jackson, W.J., Jones, C.S., Summers, A.O. and Wisdom, S. The DNA sequence of the mercury resistance operon of the IncFII plasmid NR1. J. Mol. Appl. Genet. 1984, 2, 601-619
7. Viret, J.-F., Cryz, S.J. Jr, Lang, A.B. and Favre, D. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains. Mol. Microbiol. 1993, 7, 239-252
8. Viret, J.-F. and Favre, D. Bivalent vaccines against bacterial enteropathogens: construction of live attenuated vaccine strains with two O-serotype specificities. Biologicals 1994, 22, 361-372
9. Levine, M.M. and Tacket, C.O. Recombinant live oral cholera vaccines. In: Vibrio cholerae and Cholera: Molecular to Global Perspectives (Eds Wachsmuth, I.K., Blake, P.A. and Olsvik, Ø.). American Society for Microbiology, Washington, 1994, pp. 395-413
10. Michalski, J., Galen, J.E., Fasano, A. and Kaper, J.B. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect. Immun. 1993, 61, 4462-4468
11. Gerdes, J.C. and Romig, W.R. Complete and defective bacteriophages of classical Vibrio cholerae: relationship to the kappa type bacteriophage. J. Virol. 1975, 15, 1231-1238
12. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning. A Laboratory Manual (2nd Edn). Cold Spring Harbor Laboratory Press, New York, 1989
13. Keen, N.T., Tamaki, S., Kobayashi, D. and Trollinger, D. Improved broad-host-range plasmids for DNA cloning in Gram-negative bacteria. Gene 1988, 70, 191-197
14. Evans, D.G., Evans Jr, D.J. and Tjoa, W. Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect. Immun. 1977, 18, 330-337
15. Pitcher, D.G., Saunders, N.A. and Owen, R.J. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 1989, 8, 151-156
16. Pearson, G.D.N., Woods, A., Chiang, S.L. and Mekalanos, J.J. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc. Natl Acad. Sci. USA 1993, 90, 3750-3754
17. Mekalanos, J.J. Duplication and amplification of toxin genes in Vibrio cholerae. Cell 1983, 35, 253-263
18. Cook, W.L., Wachsmuth, K., Johnson, S.R., Birkness, K.A. and Samadi, A.R. Persistence of plasmids, cholera toxin genes, and prophage DNA in classical Vibrio cholerae O1. Infect. Immun. 1984, 45, 222-226
19. Wachsmuth, K., Olsvik, Ø, Evins, G.M. and Popovic, T. Molecular epidemiology of cholera. In: Vibrio cholerae and Cholera: Molecular to Global Perspectives (Eds Wachsmuth, I.K., Blake, P.A. and Olsvik, Ø.). American Society for Microbiology, Washington, 1994, pp. 357-370
20. Kaper, J.B., Lockman, H., Baldini, M.M. and Levine, M.M. A recombinant live oral cholera vaccine. Bio/technology 1984, 2, 345-349
21. Figurski, D.H. and Helinski, D.R. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl Acad. Sci. USA 1979, 76, 1648-1652
22. Ruvkun, G.R. and Ausubel, F.M. A general method for site-directed mutagenesis in prokaryotes. Nature 1981, 289, 85-88
23. Waldor, M. K. and Mekalanos, J.J. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J. Infect. Dis. 1994, 170, 278-283
24. Taylor, D.N., Killeen, K.P., Hack, D.C. et al. Development of a live, oral, attenuated vaccine against El Tor cholera. J. Infect. Dis. 1994, 170, 1518-1523
25. Coster, T.S., Killeen, K.P., Waldor, M.K. et al. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 1995, 345, 949-952
26. Ketley, J.M., Kaper, J.B., Herrington, D.A., Losonsky, G. and Levine, M.M. Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103. Infect. Immun. 1990, 58, 1481-1484
27. Kaper, J.B., Michalski, J., Ketley, J.M. and Levine, M.M. Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR. Infect. Immun. 1994, 62, 1480-1483